Skip to Main Content

Author Details

Renea A Taylor
Peter MacCallum Cancer Centre
1999
87
31
PMIDPaper TitleJournal TitlePublished Year
36629386Advances in preclinical models of prostate cancer for research discovery.J Endocrinol2023
36650259The future of patient-derived xenografts in prostate cancer research.Nat Rev Urol2023
36608258Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts.Mol Oncol2023
36574015Multi-substrate Metabolic Tracing Reveals Marked Heterogeneity and Dependency on Fatty Acid Metabolism in Human Prostate Cancer.Mol Cancer Res2023
36765657Cell-Type-Specific Signalling Networks Impacted by Prostate Epithelial-Stromal Intercellular Communication.Cancers (Basel)2023
34687792Hidden clues in prostate cancer - Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification.Cancer Lett2022
35855555Novel germline mutations for active surveillance and imaging strategies in prostate cancer.Curr Opin Urol2022
35413990OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer.Sci Rep2022
36923279Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer.Cancer Res Commun2022
35869742New approaches to targeting epigenetic regulation in prostate cancer.Curr Opin Urol2022
35993976Novel Therapeutic Targets and Biomarkers Associated with Prostate Cancer-Associated Fibroblasts (CAFs).Crit Rev Oncog2022
36169805Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming.Cell Oncol (Dordr)2022
35892882Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer.Cancers (Basel)2022
35158771Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer.Cancers (Basel)2022
35127483Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?Front Oncol2022
34784097Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta-analysis.BJU Int2022
33406413Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer.Cell Rep2021
33620092Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancer.J Pathol2021
33843278Proteome analysis of human adipocytes identifies depot-specific heterogeneity at metabolic control points.Am J Physiol Endocrinol Metab2021
33799802Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment.Cancers (Basel)2021
34413304The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.Nat Commun2021
34413130CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition.Mol Cancer Ther2021
34111999High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.SLAS Discov2021
32132214Knowing what's growing: Why ductal and intraductal prostate cancer matter.Sci Transl Med2020
33094211PDX: Moving Beyond Drug Screening to Versatile Models for Research Discovery.J Endocr Soc2020
32603261Impact of human visceral and glutealfemoral adipose tissue transplant on glycemic control in a mouse model of diet-induced obesity.Am J Physiol Endocrinol Metab2020
32188493Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.Clin Epigenetics2020
32519789Early intervention exercise training does not delay prostate cancer progression in Pten<sup>-/-</sup> mice.Prostate2020
30901730Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.Neoplasia2019
31212368Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.Prostate2019
31519776Unsuspected Protumorigenic Signaling Role for the Oncometabolite GABA in Advanced Prostate Cancer.Cancer Res2019
30808988The influence of BRCA2 mutation on localized prostate cancer.Nat Rev Urol2019
31042478Identification of Metabolically Distinct Adipocyte Progenitor Cells in Human Adipose Tissues.Cell Rep2019
31061140Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.Mol Cell Proteomics2019
30728288Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer.Sci Transl Med2019
28977728Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cells.BJU Int2018
30049486Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.Eur Urol2018
30073676Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.Prostate2018
29650553Enduring epigenetic landmarks define the cancer microenvironment.Genome Res2018
29311126Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models.Cold Spring Harb Perspect Med2018
27718274The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.Prostate2017
28342640Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories.Eur Urol2017
28603917A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.J Pathol2017
28067867Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.Nat Commun2017
26954333Enhancing active surveillance of prostate cancer: the potential of exercise medicine.Nat Rev Urol2016
26585945Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.Urol Oncol2016
27617737A community-based model of rapid autopsy in end-stage cancer patients.Nat Biotechnol2016
27177552Patient-Derived Prostate Cancer: from Basic Science to the Clinic.Horm Cancer2016
27528024A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts.Oncotarget2016
27351281Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts.Oncotarget2016
  • 1 - 50 of 87

Recommended Authors

Preston D Crowell
University of California los angeles
Career Start Year 2017
Number of shared co-authors 5
Gervaise H Henry
UT Southwestern Medical Center
Career Start Year 2014
Number of shared co-authors 4
Xinpei Ci
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 7
Himisha Beltran
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 18
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 7
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 1
Andrew S Goldstein
University of California los angeles
Career Start Year 2008
Number of shared co-authors 2
Douglas W Strand
University of Texas Southwestern Medical Center
Career Start Year 2008
Number of shared co-authors 4
Alastair Davies
University of British Columbia
Career Start Year 2008
Number of shared co-authors 7
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 8
Tamara L Lotan
Johns Hopkins University School of Medicine
Career Start Year 2006
Number of shared co-authors 14
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 10
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 12
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 4
Antonio Hurtado-Coll
University of British Columbia
Career Start Year 2002
Number of shared co-authors 8
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 15
Ilsa Coleman
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 10
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 9
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 4
Isla P Garraway
David Geffen School of Medicine University of California Los Angeles
Career Start Year 1993
Number of shared co-authors 6
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 16
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 6
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 2
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 11
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 12
Martin E Gleave
University of British Columbia
Career Start Year 1987
Number of shared co-authors 22
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 16
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 14
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Career Start Year 1981
Number of shared co-authors 11
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 10

Collaborators

Gail P Risbridger
Biomedicine Discovery Institute, Monash University
Co-authored papers 73
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Co-authored papers 31
Mark Frydenberg
Monash University
Co-authored papers 26
David Clouston
Co-authored papers 13
Melissa Papargiris
Biomedicine Discovery Institute, Monash University
Co-authored papers 13
Matthew J Watt
Co-authored papers 11
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 10
Damien Bolton
University of Melbourne
Co-authored papers 9
Heather Thorne
Peter MacCallum Cancer Centre
Co-authored papers 9
Luke A Selth
Adelaide Medical School, University of Adelaide
Co-authored papers 5
Richard J Rebello
University of Melbourne
Co-authored papers 5
Yuzhuo Wang
University of British Columbia
Co-authored papers 3
Eva Corey
University of Washington School of Medicine
Co-authored papers 3
Arun A Azad
Peter MacCallum Cancer Centre
Co-authored papers 3
Kaylene J Simpson
The University of Melbourne, Peter MacCallum Cancer Centre
Co-authored papers 3
Richard B Pearson
Co-authored papers 2
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 2
Ania Sliwinski
The Sir Peter MacCallum Department of Oncology University of Melbourne
Co-authored papers 2
Gillian Mitchell
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
David M Berman
Queen's University
Co-authored papers 2
Nora M Navone
MD Anderson Cancer Center
Co-authored papers 2
Robert G Bristow
University of Toronto
Co-authored papers 2
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Daniel K Nomura
University of California berkeley
Co-authored papers 1
Md Nazmul Karim
Co-authored papers 1
Kara L Britt
Co-authored papers 1
Amina Zoubeidi
University of British Columbia
Co-authored papers 1
Winnie Lo
The Hospital for Sick Children
Co-authored papers 1
Makoto R Hara
Co-authored papers 1
Release 1.2